145757-47-7 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide is used as a pharmaceutical compound for its potential therapeutic applications. Its unique structure allows for interactions with various biological targets, making it a promising candidate for the development of new drugs.
Used in Chemical Research:
In the field of chemical research, 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide serves as a valuable compound for studying the properties and reactivity of imidazoline-based radicals. This can lead to a better understanding of their potential applications in various chemical processes and reactions.
Used in Material Science:
2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide can be utilized in material science as a component in the development of novel materials with specific properties. Its unique structure and reactivity may contribute to the creation of advanced materials with applications in various industries, such as electronics, aerospace, and automotive.
Used in Analytical Chemistry:
As an organic radical, 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide can be employed in analytical chemistry for the development of new methods and techniques for the detection and analysis of various compounds. Its distinctive properties may enhance the sensitivity and selectivity of analytical methods, leading to improved accuracy in chemical measurements.
Check Digit Verification of cas no
The CAS Registry Mumber 145757-47-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,7,5 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 145757-47:
(8*1)+(7*4)+(6*5)+(5*7)+(4*5)+(3*7)+(2*4)+(1*7)=157
157 % 10 = 7
So 145757-47-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H17N2O4/c1-13(2)14(3,4)16(20)11(15(13)19)9-5-7-10(8-6-9)12(17)18/h5-8H,1-4H3,(H,17,18)
145757-47-7Relevant academic research and scientific papers
NO Donor compound as well as preparation method and application thereof
-
Paragraph 0097-0099, (2021/11/26)
The invention discloses NO donor compounds and a preparation method and application thereof, wherein the compound is a drug active component formed by splicing 5 - monoisosorbide mononitrate and NIT type nitroxide radicals, and the structure is shown I. A
Agent for treatment of viral infections
-
, (2008/06/13)
A method for treatment of viral infections which comprises administering to the patients being suffering from said viral infections an effective amount of one or more substances selected from the group consisting of nitric oxide scavengers and nitric oxide synthase inhibitors. Said method for treatment of viral infections is useful in viral infections induced by influenza virus, herpes virus, hepatitis virus, cytomegalovirus, human immunodeficiency virus, etc.
Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite
-
, (2008/06/13)
The process of treating a disease of the central nervous system with an agent from one or more of the following three classes of agents: (1) nitric oxide scavengers, (2) peroxynitrite scavengers, and (3) agents that either interfere with the synthesis of iNOS in the cell or the enzymatic activity of iNOS in the cell.
The Oxidation of Two New 1,3-Dihydroxyimidazolidines - Synthesis and Structure of Nitronyl Nitroxide Radicals
Baetz, Christof,Amann, Peter,Deiseroth, Hans-Joerg,Dulog, Lothar
, p. 739 - 740 (2007/10/02)
The two new 1,3-dihydroxyimidazolidines 3a and 3b were prepared by condensation of 4-formylbenzoic acid (2a) and sodium glyoxylate (2b) with 2,3-dimethyl-2,3-butanediylbis(hydroxylamine) sulfate (1).The 1,3-dihydroxyimidazolidines were oxidized with sodiu
